![Que Huong Dong](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Que Huong Dong
Directeur Général chez
ELECTRA THERAPEUTICS, INC.
Fortune : 5 $ au 31/08/2026
Profil
Dr. Que Huong Dong is a President, Chief Executive Officer & Director at Electra Therapeutics, Inc. She is on the Board of Directors at Electra Therapeutics, Inc. and Neuron23, Inc. Dr. Dong was previously employed as a Chief Operating Officer by Star Therapeutics, Inc., a Chief Operating Officer by Vega Therapeutics, Inc., a Head-New Product Planning by Sanofi, a Director-HCV Marketing by Gilead Sciences, Inc., and a Vice President-Commercial Development by True North Therapeutics, Inc. She received her MBA from the University of New Mexico School of Medicine and a doctorate degree from the University of New Mexico School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/09/2026 | 455 484 ( 1,16% ) | 5 $ | 31/08/2026 |
Postes actifs de Que Huong Dong
| Sociétés | Poste | Début |
|---|---|---|
| ELECTRA THERAPEUTICS, INC. | Directeur Général | 01/10/2023 |
Neuron23, Inc.
 Neuron23, Inc. Pharmaceuticals: OtherHealth Technology Operates as a biotechnology company that focuses on developing precision medicines for genetically defined neurological and immunological diseases | Directeur/Membre du Conseil | 14/06/2022 |
Anciens postes connus de Que Huong Dong
| Sociétés | Poste | Fin |
|---|---|---|
Star Therapeutics, Inc.
 Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies for hematology and immunology problems | Directeur des opérations | 01/10/2023 |
Vega Therapeutics, Inc.
 Vega Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engagers in R&D and manufactures antibodies that targets proteins | Directeur des opérations | 01/10/2023 |
| SANOFI | Corporate Officer/Principal | 01/03/2019 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Corporate Officer/Principal | - |
Formation de Que Huong Dong
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
48
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
University of New Mexico School of Medicine
 University of New Mexico School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vega Therapeutics, Inc.
Vega Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engagers in R&D and manufactures antibodies that targets proteins | Health Technology |
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Health Technology |
Neuron23, Inc.
Neuron23, Inc. Pharmaceuticals: OtherHealth Technology Operates as a biotechnology company that focuses on developing precision medicines for genetically defined neurological and immunological diseases | Health Technology |
Electra Therapeutics, Inc.
 Electra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapies for immunological and cancer diseases | Health Technology |
Star Therapeutics, Inc.
Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies for hematology and immunology problems | Health Technology |
